Document is current
Any future updates will be listed below
-
Authors
Medina-Hernández, Danielle
Galán-Arriola, Carlos
Ibáñez, Borja
-
Funding
Funding for this research was provided by:
Ministerio de Ciencia e Innovación (PID2019-107332RB-I00)
Centro Nacional de Investigaciones Cardiovasculares Carlos III
Sociedad Española de Cardiología
Instituto de Salud Carlos III
European Commission
- License Information
-
More Information
This article is maintained by: Elsevier
Article Title: The quest for the mechanism responsible for the cardiovascular benefits of novel antidiabetic agents
Journal Title: REC: CardioClinics
CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.rccl.2022.09.002
Content Type: article
Copyright: © 2022 Sociedad Española de Cardiología. Published by Elsevier España, S.L.U. All rights reserved.
